Author’s reply: can budesonide form be alterative treatment for ulcerative proctosigmoiditis?
Letter to the Editor
- 40 Downloads
Compliance with ethical standards
Conflict of interest disclosure
Makoto Naganuma received research grants from EA Pharma Co., Ltd. and Zeria Pharmaceutical Co., Ltd., outside the submitted manuscript.
- 2.Naganuma M, Aoyama N, Tada T, et al. Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study. J Gastroenterol. 2018;53:579–581.CrossRefPubMedGoogle Scholar
© Japanese Society of Gastroenterology 2018